Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Arthrex, Inc.
Supreme Court nominee issued three decisions on Hatch-Waxman regime as district court judge, including case in which she ruled against the FDA’s denial of orphan drug designation and another in which she deferred to the agency’s view on exclusivity. Her analysis of facts may play a role if the court takes up a case on administrative agency deference.
Arthrex reportedly paid a physician to use the company’s orthopedic products. Separately, multiple telehealth-related false-billing schemes landed six men in hot water.
A new Informa Meddevicetracker report outlines projections for the fracture fixation devices market.
The US Supreme Court found that the role of administrative judges in patent review was unconstitutional but could be fixed by giving the PTO’s director more oversight, reinforcing the staying power of the patent appeals process.
- Implantable Devices
Surgical Equipment & Devices
- Minimally or Less Invasive
- Other Names / Subsidiaries
- MX Orthopedics